MariMed (MRMD) Stock Price, News & Analysis

Company Overview

MariMed, Inc. is a U.S. cannabis company that develops, operates and manages regulated cannabis cultivation, processing and retail facilities. The company follows a vertically integrated business model, producing cannabis products and selling them through its own dispensaries and other authorized channels.

MariMed offers a range of cannabis products, including flower, pre-rolls, concentrates, edibles, tinctures and topical products. Its portfolio includes brands such as Betty’s Eddies, Nature’s Heritage, Bubby’s Baked and Kalm Fusion, which are marketed for recreational and medical-use consumers where permitted by state law.

The company serves regulated cannabis markets in several states, including Delaware, Maryland, Massachusetts and Ohio. MariMed was established in 2011 and is headquartered in Newton, Massachusetts. Jon Levine, a co-founder of the company, serves as its chief executive officer.

Key Stats

• Today's Range: $0.07 to $0.08
• 50-Day Range: $0.06 to $0.09
• 52-Week Range: $0.06 to $0.18
• Volume: 761,565 shs
• Average Volume: 544,972 shs
• Market Capitalization: $28.29 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

MariMed Stock Analysis - MarketRank™

MariMed scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

MariMed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

MariMed has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of MariMed is -1.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of MariMed is -1.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

MariMed has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of MariMed has been sold short.

Short Interest Ratio / Days to Cover

MariMed has a short interest ratio ("days to cover") of 0.06, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MariMed has recently increased by 112.72%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

MariMed does not currently pay a dividend.

Dividend Growth

MariMed does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.13

News Sentiment

MariMed has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for MariMed this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MariMed insiders have not sold or bought any company stock.

Percentage Held by Insiders

16.05% of the stock of MariMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.18% of the stock of MariMed is held by institutions.

Company Calendar

• Last Earnings: 8/12/2026
• Today: 9/30/2026
• AGM 2026: 10/28/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MRMD
• Previous Symbol: OTC:MRMD
• CIK: 1522767
• Web: marimedinc.com
• Phone: (617) 795-5140
• Fax: N/A
• Employees: 260
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.48 million
• Net Margins: -9.13%
• Pretax Margin: -6.21%
• Return on Equity: -10.71%
• Return on Assets: -2.58%

Debt

• Debt-to-Equity Ratio: 1.78
• Current Ratio: 0.92
• Quick Ratio: 0.34

Sales & Book Value

• Annual Sales: $159.83 million
• Price / Sales: 0.18
• Cash Flow: $0.02 per share
• Price / Cash Flow: 3.17
• Book Value: $0.13 per share
• Price / Book: 0.54

Miscellaneous

• Outstanding Shares: 402,955,000
• Free Float: 338,281,000
• Market Cap: $28.29 million
• Optionable: Not Optionable
• Beta: 1.35